Logo
Picture

Expanded Access Summit @Expanded_Access

Ax-S Pharma, producer of the annual global conference on integrating pre-approval access into clinical drug development. easummit.net Washington, DC Joined April 2018
  • Tweets
    248
  • Followers
    630
  • Following
    3K
  • Likes
    131
Expanded_Access Profile Picture

Expanded Access Summit @Expanded_Access

5 years ago

@maxwellsmith In the U.S., people won't get vaxxed because they're told it's good for them or good for public health. They'll do it because it's required at every workplace, store, airport, or gathering. As you say, it's a choice, not a mandate.

Expanded_Access Profile Picture

Expanded Access Summit @Expanded_Access

5 years ago

@maxwellsmith Liberty is not counterpositioned to safety in this matter. A true libertarian supports an organization's right to protect its workforce, customers, guests, and attendees by denying entry to unvaxxed people. The public health "mandate" concept is misleading and problematic.

Expanded_Access Profile Picture

Expanded Access Summit @Expanded_Access

5 years ago

@bsw5020 @US_FDA Here's how EA helps research trials, as we presented at NEALS #ALS forums 2013-2016. #ExpandedAccess programs, if made visible in advance, assure research trial participants that they'll have option to continue w/ active drug upon completion of study. Recruitment AND Retention.

Expanded_Access Profile Picture

Expanded Access Summit @Expanded_Access

5 years ago

@momwithwheels @Michell62614519 @bsw5020 @US_FDA @HELPCmteDems @SenBlumenthal @SenatorHick @SenJackyRosen @timkaine @SenSanders @SenTinaSmith @SenatorHassan @SenatorLujan @ChrisMurphyCT @DrWoodcockFDA FDA's position and @DrWoodcockFDA position on #ExpandedAccess has been excellent. The OP may be referring to the oft-repeated motto "the surest way to bring a new treatment to the most people is through well-controlled clinical trials", which (falsely) implies conflict with EA.

Expanded Access Summit retweeted
BusinessInsider Profile Picture

Business Insider @BusinessInsider

5 years ago

Despite some criticism, business owners said the overwhelming majority of people applauded them for requiring vaccines upon entry. businessinsider.com/business-owner…

Expanded_Access Profile Picture

Expanded Access Summit @Expanded_Access

5 years ago

@gregggonsalves Although, comparing to seatbelts in cars is vulnerable to a libertarian counterargument, because failing to buckle up only harms the decision-maker. In contrast, failing to get SARS-COV2 vax harms the rest of us by prolonging the pandemic & putting other individuals at high risk

Expanded_Access Profile Picture

Expanded Access Summit @Expanded_Access

5 years ago

@gregggonsalves @RonDeSantisFL @GovAbbott We absolutely agree on this one!

Expanded_Access Profile Picture

Expanded Access Summit @Expanded_Access

5 years ago

@ProfRobHoward @gregggonsalves @US_FDA @icer_review @MadhavThambiset Yes, our name reflects our dedication to access - to modern healthcare, to investigational treatment options, and to the learning that can be generated by integrating research into widespread care practice. Call us crazy, but we think access is the key to a lot of good things.

Expanded_Access Profile Picture

Expanded Access Summit @Expanded_Access

5 years ago

@gregggonsalves @US_FDA @icer_review @MadhavThambiset @ProfRobHoward Interpret it how you want. Misrepresent it if you want. But our comments are clear, and they're consistent with the law and with FDA's flexibility around treatment access in diseases where flexibility is needed most.

Expanded_Access Profile Picture

Expanded Access Summit @Expanded_Access

5 years ago

@gregggonsalves @ProfRobHoward Luckily the second is not a precondition for the first. Nevertheless we know the history, and there are many cases of EAP-generated datasets contributing substantially to the body of knowledge on the particular treatment and disease, perhaps more-so in cancer EAPs than AIDS.

Expanded_Access Profile Picture

Expanded Access Summit @Expanded_Access

5 years ago

@nadia_sethi Ha! It took me a while too. Here is the trick: Don't pronounce all 7 syllables. Say: Neuro-De-GenRative. We should have provided this to the Committee members today!

Expanded_Access Profile Picture

Expanded Access Summit @Expanded_Access

5 years ago

More questions from Committee members about how to make #ClinicalTrials more inclusive. FDA missing a huge opportunity to educate lawmakers about #ExpandedAccess channel, which is the intended channel for humanitarian widening of eligibility for investigational treatment.

Expanded_Access Profile Picture

Expanded Access Summit @Expanded_Access

5 years ago

Research trials need to be diverse, but not broadly inclusive in terms of numbers of patients. The clinical research enterprise was not created to provide a treatment option for whole populations. That's what #ExpandedAccess is for.

Expanded_Access Profile Picture

Expanded Access Summit @Expanded_Access

5 years ago

Congressional Hearing on funding for #ExpandedAccess in #ALS taking place right now. We'll be fact checking the whole way. energycommerce.house.gov/committee-acti…

Expanded_Access Profile Picture

Expanded Access Summit @Expanded_Access

5 years ago

Rep Sarbanes, re Section 610 of PDUFA 6, requiring examination of trial inclusion/exclusion criteria. Ax-S Pharma: We authored some of the key language in this law to make sure the focus remained on utilizing #ExpandedAccess to increase overall inclusivity.

Expanded_Access Profile Picture

Expanded Access Summit @Expanded_Access

5 years ago

Castor: Guidance advises larger, secondary cohorts to explore differential response. How has industry responded to this?

Expanded_Access Profile Picture

Expanded Access Summit @Expanded_Access

5 years ago

Cavazzoni: It's a very special disease with particularly challenging factors in clinical development. Also much greater tolerance for risk in the patient community wrt benefit/risk tradeoff.

Expanded_Access Profile Picture

Expanded Access Summit @Expanded_Access

5 years ago

Rep Burgess; is FDA utilizing data generated by the Federally funded ALS Registry? A: not prepared to answer

Trends for United States

Todd Blanche
Batman
Lindell
Simeone
England vs Argentina
Clayton
Yzerman
JJ Abrams
#ENGARG
#NationalHotDogDay
Ossoff
Rocky
NRED
Larkin
Rotten Tomatoes
Kareem
Matt Reeves
Stallone
#Rashmer
Standard

You might like

PharmaShots | Your partner in biopharma & healthcare insights. Connecting decision-makers & brands through sharp news, impactful insights and leader interviews
PharmaShots | Ilumina...
@Pharmashot
2K Followers
Professor of Practice, Clinical and Regulatory Affairs
L.J.Davis, PharmD
@MedicineDigest
362 Followers
#Biopharma #AI #Healthcare #RWE enthusiast | #musicophile #photographer | Interest: #AI #MnA #Medicaldevices #Digitalhealth #EMR | Tweets/post r personal!
Adi Singh
@adisingh_
591 Followers
#myTomorrows - | CCO | NY | #preapprovalaccess | #digitalhealth | tweets are my own | #savingmankind | #pinksocks | Podcastlover
Dennis Akkaya
@DenimDennis
478 Followers
Octavus is a boutique consulting, engaged in comprehensive business & competitive intelligence, market assessment & conference coverage to Lifesciences industry
Octavus Consulting
@consultoctavus
515 Followers